Montefiore Health System: Common Blood Test Identifies Benefits and Risks of Steroid Treatment in COVID-19 Patients
July 23, 2020
July 23, 2020
BRONX, New York, July 23 -- Montefiore Health System issued the following joint news release:
A new study led by Albert Einstein College of Medicine and Montefiore Health System confirms the findings of the large scale British trial of steroid use for COVID-19 patients and advances the research by answering several key questions: Which patients are most likely to benefit from steroid therapy? Could some of them be harmed? Can other formulations of steroids substitute for the agent . . .
A new study led by Albert Einstein College of Medicine and Montefiore Health System confirms the findings of the large scale British trial of steroid use for COVID-19 patients and advances the research by answering several key questions: Which patients are most likely to benefit from steroid therapy? Could some of them be harmed? Can other formulations of steroids substitute for the agent . . .